• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMG:GR

106.967 EUR 0.067 0.06%

As of 04:25:19 ET on 09/17/2014.

Snapshot for Amgen Inc (AMG)

Open: 107.270 Day's Range: 106.967 - 107.723 Volume: 782
Previous Close: 106.900 52wk Range: 78.310 - 108.700 1-Yr Rtn: +26.20%

Stock Chart for AMG

No chart data available.
  • AMG:GR 106.967
  • 1D
  • 1M
  • 1Y
106.900
Interactive AMG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 16.5020
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 8.3890
Est. PEG Ratio 1.9952
Market Cap (M EUR) 81,202.01
Shares Outstanding (M) 759.61
30 Day Average Volume 3,497
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.70%
Cash Dividend (USD) 0.6100
Dividend Ex-Date 08/12/2014
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMG

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Robert A Bradway "Bob"Chairman/President/CEODavid W MelineExec VP/CFO
Anthony C Hooper "Tony"Exec VP:Global Commercial OpsBrian M McNameeExec VP:Full Potential Initiatives
More Company Profile & Key Executives for AMG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil